Site icon Market Stats News

Branched Stent Grafts Market Size to Rake US$ 501.53 Mn by 2030

The global Branched Stent Grafts market size is expected to be worth around US$ 501.53 Mn by 2030, according to a new report by Vision Research Reports.

Branched Stent Grafts Market (By Type: Iliac Stent, Others; By Application: EVAR) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38320

Growth Factor

Continued robust growth in segments is an outcome of the growing diagnostic capturing of pre-ruptured aneurysms, expanding clinical coverage, and an overarching trend for endovascular aneurysm repair. In addition, the preference for endovascular treatment for aortic aneurysms further boosts the market growth.

Around 28 million vascular surgeries have been postponed or canceled globally at the peak of the COVID-19 pandemic, which can seriously affect the market. Restrictions on the movement of goods and people gradually led to a decline in the uptake of nonelective surgeries, such as those resulting from trauma or acute conditions. In addition, extended factory closures by companies in several countries slowed down the manufacturing of products.

The branched stent grafts market report contains company profiles of the top companies operating in the market along with their respective revenue and operating segments, market footprint, strategic developments, headquarters, growth rates, recent developments, product /services, expansion strategies, investments in expansion, and more.

This branched stent grafts market report offers historical data points and forecasts and revenue growth at a global, regional, and country level, latest industry trends, and consumption pattern details for each region, major country, and segment from 2021 to 2030.

The market report also covers technical data, manufacturing and production costs, research and development activities, regulatory framework, economic factors, and globalization. The report further segments the branched stent grafts market on the basis of Leading Companies Profiled, and key regions of branched stent grafts market.

Key Players

Market Segmentation

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38320

The study objectives of this report are:

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Branched Stent Grafts Market, By Application

7.1.  Branched Stent Grafts Market, by Application, 2021-2030

7.1.1.    EVAR

7.1.1.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Branched Stent Grafts Market, By Type

8.1.  Branched Stent Grafts Market, by Type, 2021-2030

8.1.1.    Iliac Stent

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Others

8.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Branched Stent Grafts Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Application (2016-2030)

9.1.2.    Market Revenue and Forecast, by Type (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Application (2016-2030)

9.1.3.2.        Market Revenue and Forecast, by Type (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Application (2016-2030)

9.1.4.2.        Market Revenue and Forecast, by Type (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Application (2016-2030)

9.2.2.    Market Revenue and Forecast, by Type (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Application (2016-2030)

9.2.3.2.        Market Revenue and Forecast, by Type (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Application (2016-2030)

9.2.4.2.        Market Revenue and Forecast, by Type (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Application (2016-2030)

9.2.5.2.        Market Revenue and Forecast, by Type (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Application (2016-2030)

9.2.6.2.        Market Revenue and Forecast, by Type (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Application (2016-2030)

9.3.2.    Market Revenue and Forecast, by Type (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Application (2016-2030)

9.3.3.2.        Market Revenue and Forecast, by Type (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Application (2016-2030)

9.3.4.2.        Market Revenue and Forecast, by Type (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Application (2016-2030)

9.3.5.2.        Market Revenue and Forecast, by Type (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Application (2016-2030)

9.3.6.2.        Market Revenue and Forecast, by Type (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Application (2016-2030)

9.4.2.    Market Revenue and Forecast, by Type (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Application (2016-2030)

9.4.3.2.        Market Revenue and Forecast, by Type (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Application (2016-2030)

9.4.4.2.        Market Revenue and Forecast, by Type (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Application (2016-2030)

9.4.5.2.        Market Revenue and Forecast, by Type (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Application (2016-2030)

9.4.6.2.        Market Revenue and Forecast, by Type (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Application (2016-2030)

9.5.2.    Market Revenue and Forecast, by Type (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Application (2016-2030)

9.5.3.2.        Market Revenue and Forecast, by Type (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Application (2016-2030)

9.5.4.2.        Market Revenue and Forecast, by Type (2016-2030)

Chapter 10.  Company Profiles

10.1.              Medtronic

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Biotronik

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Alvimedica

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Endocor GmbH

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Eucatech AG

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Merit Medical Systems

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Abbott

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Cook Medical

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Cardinal Health (Cordis)

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Boston Scientific Corp.

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

10.11.           Terumo Corp.

10.11.1.               Company Overview

10.11.2.               Product Offerings

10.11.3.               Financial Performance

10.11.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38320

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Exit mobile version